Thrombogenics N.V. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
112,781.00
13,776.00
11,198.00
7,104.00
9,055.00
5,320
Cost of Goods Sold (COGS) incl. D&A
14,067.00
12,730.00
11,217.00
14,558.00
6,409.00
6,982
Gross Income
98,714.00
1,046.00
19.00
7,454.00
2,646.00
1,662
SG&A Expense
73,252.00
53,818.00
38,996.00
27,882.00
29,829.00
38,462
EBIT
25,462.00
52,781.00
39,015.00
35,336.00
27,183.00
40,124
Unusual Expense
-
3.00
11.00
26,584.00
2.00
10
Non Operating Income/Expense
461.00
856.00
778.00
1,402.00
49,788.00
1,224
Interest Expense
-
33.00
37.00
36.00
31.00
24
Pretax Income
26,414.00
50,975.00
37,890.00
60,370.00
22,629.00
38,769
Income Tax
13.00
140.00
42.00
22.00
14.00
10
Consolidated Net Income
26,401.00
51,115.00
37,932.00
60,348.00
22,615.00
38,779
Net Income
26,401.00
51,115.00
37,884.00
60,314.00
22,788.00
38,474
Net Income After Extraordinaries
26,401.00
51,115.00
37,884.00
60,314.00
22,788.00
38,474
Net Income Available to Common
26,401.00
51,115.00
37,884.00
60,314.00
22,788.00
38,474
EPS (Basic)
0.73
1.42
1.05
1.67
0.63
1.01
Basic Shares Outstanding
36,021.20
36,094.30
36,094.30
36,094.30
36,094.30
38,250.70
EPS (Diluted)
0.71
1.39
1.03
1.65
0.62
1.01
Diluted Shares Outstanding
36,942.60
36,866.50
36,828.50
36,592.20
36,598.60
38,250.70
EBITDA
33,145.00
44,651.00
31,028.00
27,658.00
23,353.00
36,497
Other Operating Expense
-
9.00
-
-
-
-
Non-Operating Interest Income
1,413.00
986.00
395.00
184.00
53.00
165
Minority Interest Expense
-
-
48.00
34.00
173.00
305
About Thrombogenics
View Profile
